Todd Golde, MD, PhD
McKnight Brain Institute, Executive Director
Florida Alzheimer’s Disease Research Center, Principal Investigator
Glenn Smith, PhD, ABPP
UF Department of Clinical and Health Psychology, Elizabeth Faulk Professor and Chair
Michael Jaffe, MD
UF Department of Neurology, Vice Chair
UF Memory Disorder Clinic, Director
Demetrius Maraganore, MD, FAAN
UF Department of Neurology, BJ and Eve Wilder Professor
Steven DeKosky, MD
McKnight Brain Institute, Deputy Director
Florida Alzheimer’s Disease Research Center, Associate Director
UF College of Medicine, Aerts-Cosper Professor of Alzheimer’s Research
Primary Care Physicians
This CME activity consists of a pre-test, educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is one hour.
Requirements for Successful Completion
As a result of participation in this activity, participants should be able to:
Define age-related cognitive decline and distinguish between mild cognitive impairment and dementia.
Identify and modify the risk factors of cognitive impairment and dementia.
Discuss the etiologic mechanisms of Alzheimer’s disease, therapeutic targets, and emerging therapies.
Describe services provided in the state of Florida and benefits of research participation.
Dr. Dekosky is a consultant for Amgen, Biogen, and Cognition Therapeutics as well as an Editor for Dementia for UpToDate. No one else in a position to control content has any other relationships to disclose.
CME Advisory Committee Disclosure: Conflict of interest information for the CME Advisory Committee members can be found on the following website: http://cme.ufl.edu/disclosure/
Continuing Medical Education Credit
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date: October 11, 2019
Expiration Date: June 30, 2021